Ellume Limited products

In partnership with global diagnostics company QIAGEN®, Ellume has developed two rapid COVID-19 tests: the QIAreach™ SARS-CoV-2 Antigen Test**** for active infections and the QIAreach™ Anti-SARS-CoV-2 Total Test** for past infections. Both tests are now available in the U.S. The tests are run on the eHub platform, an easy-to-use and portable digital device that provides results in less than 15 minutes.

The Ellume COVID-19 Home Test is an over-the-counter, rapid self-test which detects SARS-CoV-2 antigen. The test is suitable for ages 2 years and above for over-the-counter home use in the U.S*. Clinically proven for use for people with and without symptoms, with accurate test results in 15 minutes. The app will guide you through the test including an integrated information video and step-by-step instructions. The sample is analyzed and the result is displayed on your phone after 15 minutes. Results are saved within the app and can be shared via email. The Ellume COVID-19 Home Test complies with CDC reporting requirements and automatically reports the required data to health authorities through our secure encrypted, HIPAA compliant, cloud connection.

ellume·lab is a versatile, handheld digital device designed for healthcare professionals at the point of care. ellume·lab offers a growing range of highly accurate, rapid diagnostic tests for the detection of common infectious diseases. Two tests can be performed at the same time, with simple, animated on-screen instructions and rapid results in 15 minutes. The COVID Antigen test (for the detection of active COVID-19 infections) is currently available***. The COVID Serology test (for the detection of total antibodies to SARS-CoV-2) is pending regulatory clearance.

We have created a highly accurate digital test, which enables a user to detect influenza in 12 minutes. The Ellume Pandemic Influenza Self-test connects to a user’s smartphone and provides simple, step-by-step, on-screen instructions through the test’s app. The app also allows direct access to clinical advice and treatment. We are working closely with relevant health authorities to connect into aggregated data in real-time, allowing for immediate response during pandemic outbreaks.